Page 146 - GPD-3-2

Gene & Protein in Disease Placenta, FASD, and soy

doi: 10.4172/2324-9293.1000133 39. Stenflo J, Lundwall A, Dahlback B. Beta-hydroxyasparagine
36. Aihara A, Huang CK, Olsen MJ, et al. A cell-surface in domains homologous to the epidermal growth factor
β-hydroxylase is a biomarker and therapeutic target for precursor in vitamin K-dependent protein S. Proc Natl Acad
hepatocellular carcinoma. Hepatology. 2014;60(4):1302-1313. Sci U S A. 1987;84(2):368-372.
doi: 10.1002/hep.27275 doi: 10.1073/pnas.84.2.368
37. Gundogan F, Bedoya A, Gilligan J, et al. siRNA inhibition of 40. Wagner JD, Zhang L, Shadoan MK, et al. Effects of
aspartyl-asparaginyl β-hydroxylase expression impairs cell soy protein and isoflavones on insulin resistance and
motility, Notch signaling, and fetal growth. Pathol Res Pract. adiponectin in male monkeys. Metabolism. 2008;
2011;207(9):545-553. 57(7 Suppl 1):S24-S31.
doi: 10.1016/j.prp.2011.06.001 doi: 10.1016/j.metabol.2008.04.001
38. Lavaissiere L, Jia S, Nishiyama M, et al. Overexpression 41. De la Monte SM. Malignant brain aging: The formidable link
of human aspartyl (asparaginyl) beta-hydroxylase in between dysregulated signaling through mechanistic target
hepatocellular carcinoma and cholangiocarcinoma. J Clin of rapamycin pathways and Alzheimer’s disease (type 3
Invest. 1996;98(6):1313-1323. diabetes). J Alzheimers Dis. 2023;95(4):1301-1337.
doi: 10.1172/JCI118918 doi: 10.3233/JAD-230555

Volume 3 Issue 2 (2024) 12 doi: 10.36922/gpd.3113